A DNA vaccine encoding CCL4/MIP-1β enhances myocarditis in experimental Trypanosoma cruzi infection in rats

Ester Roffê, Adriano L S Souza, Bráulia C. Caetano, Patrícia P. Machado, Lucíola S. Barcelos, Remo C. Russo, Helton C. Santiago, Danielle G. Souza, Vanessa Pinho, Herbert B. Tanowitz, Elisabeth R S Camargos, Oscar Bruña-Romero, Mauro M. Teixeira

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Chagas' disease, caused by Trypanosoma cruzi, is a major cause of cardiovascular disease in Latin America. Exacerbated inflammation disproportional to parasite load characterizes chronic myocardial lesions in chagasic patients. Chemokines and their receptors are expected to account for the renewed inflammatory processes after the inoculation of the parasite, but their potential unique functions are far from being clear. Herein, we evaluated the effect of a DNA vaccine encoding CCL4/MIP-1β, a CC-chemokine, in T. cruzi-elicited myocarditis in rats. Holtzman rats were given intramuscularly cardiotoxin and the CCL4/MIP-1β DNA-containing plasmid (100 μg) was delivered in this muscular site four times. Fourteen days after last immunization, animals were inoculated with a myotropical CL-Brener T. cruzi clone. Peak of parasitism was observed at day 15 after infection, preceding the peak of myocardial inflammation at day 20. Myocarditis was still intense at day 30, but the inflammatory infiltrates showed a more focal distribution. The expression of CCL2/MCP-1 and CCL4/MIP-1β correlated closely with the kinetics of myocardial inflammation. The CCL4/MIP-1β DNA vaccine induced an increase of the levels of the anti-CCL4/MIP-1β observed in T. cruzi-infected animals. This was associated with an exacerbation of myocardial inflammation and fibrosis, although alterations in parasitemia and myocardial parasitism were not observed. Our data suggest that CCL4/MIP-1β plays a role in preventing excessive inflammation and pathology rather than in controlling parasite replication.

Original languageEnglish (US)
Pages (from-to)2745-2755
Number of pages11
JournalMicrobes and Infection
Volume8
Issue number12-13
DOIs
StatePublished - Oct 2006

Fingerprint

DNA Vaccines
Trypanosoma cruzi
Myocarditis
Inflammation
Infection
Parasites
Cardiotoxins
Parasite Load
CC Chemokines
Parasitemia
Chagas Disease
Latin America
Chemokine Receptors
Sprague Dawley Rats
Immunization
Plasmids
Fibrosis
Cardiovascular Diseases
Clone Cells
Pathology

Keywords

  • CCL4/MIP-1β
  • Chemokine
  • DNA vaccine
  • Myocarditis
  • Trypanosoma cruzi

ASJC Scopus subject areas

  • Microbiology
  • Infectious Diseases

Cite this

Roffê, E., Souza, A. L. S., Caetano, B. C., Machado, P. P., Barcelos, L. S., Russo, R. C., ... Teixeira, M. M. (2006). A DNA vaccine encoding CCL4/MIP-1β enhances myocarditis in experimental Trypanosoma cruzi infection in rats. Microbes and Infection, 8(12-13), 2745-2755. https://doi.org/10.1016/j.micinf.2006.08.004

A DNA vaccine encoding CCL4/MIP-1β enhances myocarditis in experimental Trypanosoma cruzi infection in rats. / Roffê, Ester; Souza, Adriano L S; Caetano, Bráulia C.; Machado, Patrícia P.; Barcelos, Lucíola S.; Russo, Remo C.; Santiago, Helton C.; Souza, Danielle G.; Pinho, Vanessa; Tanowitz, Herbert B.; Camargos, Elisabeth R S; Bruña-Romero, Oscar; Teixeira, Mauro M.

In: Microbes and Infection, Vol. 8, No. 12-13, 10.2006, p. 2745-2755.

Research output: Contribution to journalArticle

Roffê, E, Souza, ALS, Caetano, BC, Machado, PP, Barcelos, LS, Russo, RC, Santiago, HC, Souza, DG, Pinho, V, Tanowitz, HB, Camargos, ERS, Bruña-Romero, O & Teixeira, MM 2006, 'A DNA vaccine encoding CCL4/MIP-1β enhances myocarditis in experimental Trypanosoma cruzi infection in rats', Microbes and Infection, vol. 8, no. 12-13, pp. 2745-2755. https://doi.org/10.1016/j.micinf.2006.08.004
Roffê, Ester ; Souza, Adriano L S ; Caetano, Bráulia C. ; Machado, Patrícia P. ; Barcelos, Lucíola S. ; Russo, Remo C. ; Santiago, Helton C. ; Souza, Danielle G. ; Pinho, Vanessa ; Tanowitz, Herbert B. ; Camargos, Elisabeth R S ; Bruña-Romero, Oscar ; Teixeira, Mauro M. / A DNA vaccine encoding CCL4/MIP-1β enhances myocarditis in experimental Trypanosoma cruzi infection in rats. In: Microbes and Infection. 2006 ; Vol. 8, No. 12-13. pp. 2745-2755.
@article{944dbc0484264fdca84a7bd2adf088aa,
title = "A DNA vaccine encoding CCL4/MIP-1β enhances myocarditis in experimental Trypanosoma cruzi infection in rats",
abstract = "Chagas' disease, caused by Trypanosoma cruzi, is a major cause of cardiovascular disease in Latin America. Exacerbated inflammation disproportional to parasite load characterizes chronic myocardial lesions in chagasic patients. Chemokines and their receptors are expected to account for the renewed inflammatory processes after the inoculation of the parasite, but their potential unique functions are far from being clear. Herein, we evaluated the effect of a DNA vaccine encoding CCL4/MIP-1β, a CC-chemokine, in T. cruzi-elicited myocarditis in rats. Holtzman rats were given intramuscularly cardiotoxin and the CCL4/MIP-1β DNA-containing plasmid (100 μg) was delivered in this muscular site four times. Fourteen days after last immunization, animals were inoculated with a myotropical CL-Brener T. cruzi clone. Peak of parasitism was observed at day 15 after infection, preceding the peak of myocardial inflammation at day 20. Myocarditis was still intense at day 30, but the inflammatory infiltrates showed a more focal distribution. The expression of CCL2/MCP-1 and CCL4/MIP-1β correlated closely with the kinetics of myocardial inflammation. The CCL4/MIP-1β DNA vaccine induced an increase of the levels of the anti-CCL4/MIP-1β observed in T. cruzi-infected animals. This was associated with an exacerbation of myocardial inflammation and fibrosis, although alterations in parasitemia and myocardial parasitism were not observed. Our data suggest that CCL4/MIP-1β plays a role in preventing excessive inflammation and pathology rather than in controlling parasite replication.",
keywords = "CCL4/MIP-1β, Chemokine, DNA vaccine, Myocarditis, Trypanosoma cruzi",
author = "Ester Roff{\^e} and Souza, {Adriano L S} and Caetano, {Br{\'a}ulia C.} and Machado, {Patr{\'i}cia P.} and Barcelos, {Luc{\'i}ola S.} and Russo, {Remo C.} and Santiago, {Helton C.} and Souza, {Danielle G.} and Vanessa Pinho and Tanowitz, {Herbert B.} and Camargos, {Elisabeth R S} and Oscar Bru{\~n}a-Romero and Teixeira, {Mauro M.}",
year = "2006",
month = "10",
doi = "10.1016/j.micinf.2006.08.004",
language = "English (US)",
volume = "8",
pages = "2745--2755",
journal = "Microbes and Infection",
issn = "1286-4579",
publisher = "Elsevier Masson SAS",
number = "12-13",

}

TY - JOUR

T1 - A DNA vaccine encoding CCL4/MIP-1β enhances myocarditis in experimental Trypanosoma cruzi infection in rats

AU - Roffê, Ester

AU - Souza, Adriano L S

AU - Caetano, Bráulia C.

AU - Machado, Patrícia P.

AU - Barcelos, Lucíola S.

AU - Russo, Remo C.

AU - Santiago, Helton C.

AU - Souza, Danielle G.

AU - Pinho, Vanessa

AU - Tanowitz, Herbert B.

AU - Camargos, Elisabeth R S

AU - Bruña-Romero, Oscar

AU - Teixeira, Mauro M.

PY - 2006/10

Y1 - 2006/10

N2 - Chagas' disease, caused by Trypanosoma cruzi, is a major cause of cardiovascular disease in Latin America. Exacerbated inflammation disproportional to parasite load characterizes chronic myocardial lesions in chagasic patients. Chemokines and their receptors are expected to account for the renewed inflammatory processes after the inoculation of the parasite, but their potential unique functions are far from being clear. Herein, we evaluated the effect of a DNA vaccine encoding CCL4/MIP-1β, a CC-chemokine, in T. cruzi-elicited myocarditis in rats. Holtzman rats were given intramuscularly cardiotoxin and the CCL4/MIP-1β DNA-containing plasmid (100 μg) was delivered in this muscular site four times. Fourteen days after last immunization, animals were inoculated with a myotropical CL-Brener T. cruzi clone. Peak of parasitism was observed at day 15 after infection, preceding the peak of myocardial inflammation at day 20. Myocarditis was still intense at day 30, but the inflammatory infiltrates showed a more focal distribution. The expression of CCL2/MCP-1 and CCL4/MIP-1β correlated closely with the kinetics of myocardial inflammation. The CCL4/MIP-1β DNA vaccine induced an increase of the levels of the anti-CCL4/MIP-1β observed in T. cruzi-infected animals. This was associated with an exacerbation of myocardial inflammation and fibrosis, although alterations in parasitemia and myocardial parasitism were not observed. Our data suggest that CCL4/MIP-1β plays a role in preventing excessive inflammation and pathology rather than in controlling parasite replication.

AB - Chagas' disease, caused by Trypanosoma cruzi, is a major cause of cardiovascular disease in Latin America. Exacerbated inflammation disproportional to parasite load characterizes chronic myocardial lesions in chagasic patients. Chemokines and their receptors are expected to account for the renewed inflammatory processes after the inoculation of the parasite, but their potential unique functions are far from being clear. Herein, we evaluated the effect of a DNA vaccine encoding CCL4/MIP-1β, a CC-chemokine, in T. cruzi-elicited myocarditis in rats. Holtzman rats were given intramuscularly cardiotoxin and the CCL4/MIP-1β DNA-containing plasmid (100 μg) was delivered in this muscular site four times. Fourteen days after last immunization, animals were inoculated with a myotropical CL-Brener T. cruzi clone. Peak of parasitism was observed at day 15 after infection, preceding the peak of myocardial inflammation at day 20. Myocarditis was still intense at day 30, but the inflammatory infiltrates showed a more focal distribution. The expression of CCL2/MCP-1 and CCL4/MIP-1β correlated closely with the kinetics of myocardial inflammation. The CCL4/MIP-1β DNA vaccine induced an increase of the levels of the anti-CCL4/MIP-1β observed in T. cruzi-infected animals. This was associated with an exacerbation of myocardial inflammation and fibrosis, although alterations in parasitemia and myocardial parasitism were not observed. Our data suggest that CCL4/MIP-1β plays a role in preventing excessive inflammation and pathology rather than in controlling parasite replication.

KW - CCL4/MIP-1β

KW - Chemokine

KW - DNA vaccine

KW - Myocarditis

KW - Trypanosoma cruzi

UR - http://www.scopus.com/inward/record.url?scp=33750733988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750733988&partnerID=8YFLogxK

U2 - 10.1016/j.micinf.2006.08.004

DO - 10.1016/j.micinf.2006.08.004

M3 - Article

VL - 8

SP - 2745

EP - 2755

JO - Microbes and Infection

JF - Microbes and Infection

SN - 1286-4579

IS - 12-13

ER -